These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Paediatric pulmonary drug delivery: considerations in asthma treatment. Berger WE Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802 [TBL] [Abstract][Full Text] [Related]
5. Aerosol therapy: the special needs of young children. Janssens HM; Tiddens HA Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606 [TBL] [Abstract][Full Text] [Related]
6. Influence of realistic airflow rate on aerosol generation by nebulizers. Vecellio L; Kippax P; Rouquette S; Diot P Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494 [TBL] [Abstract][Full Text] [Related]
7. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems. Knoch M; Keller M Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761 [TBL] [Abstract][Full Text] [Related]
8. Inhalatory therapy training: a priority challenge for the physician. Melani AS Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086 [TBL] [Abstract][Full Text] [Related]
9. The future of nebulization. Barry PW Respir Care; 2002 Dec; 47(12):1459-69; discussion 1469-70. PubMed ID: 12467503 [TBL] [Abstract][Full Text] [Related]
10. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Dhand R Respir Care; 2002 Dec; 47(12):1406-16; discussion 1416-8. PubMed ID: 12467499 [TBL] [Abstract][Full Text] [Related]
13. Systemic treatment by inhalation of macromolecules--principles, problems, and examples. Siekmeier R; Scheuch G J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():53-79. PubMed ID: 19218633 [TBL] [Abstract][Full Text] [Related]
14. New frontiers in aerosol delivery during mechanical ventilation. Dhand R Respir Care; 2004 Jun; 49(6):666-77. PubMed ID: 15165301 [TBL] [Abstract][Full Text] [Related]
15. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients. Westerman EM; Heijerman HG; Frijlink HW Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406 [TBL] [Abstract][Full Text] [Related]
16. Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials. Fischer A; Stegemann J; Scheuch G; Siekmeier R Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):71-7. PubMed ID: 20156730 [TBL] [Abstract][Full Text] [Related]
17. Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods. Dopfer R; Brand P; Müllinger B; Hunger T; Häussermann S; Meyer T; Scheuch G; Siekmeier R J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):141-54. PubMed ID: 18204125 [TBL] [Abstract][Full Text] [Related]
18. Ultrasonic nebulization platforms for pulmonary drug delivery. Yeo LY; Friend JR; McIntosh MP; Meeusen EN; Morton DA Expert Opin Drug Deliv; 2010 Jun; 7(6):663-79. PubMed ID: 20459360 [TBL] [Abstract][Full Text] [Related]
19. Aerosol delivery devices in the treatment of asthma. Hess DR Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026 [TBL] [Abstract][Full Text] [Related]
20. [An apparatus for producing aerosols and depositing aerosols in the bronchial tree]. Bizjak M Plucne Bolesti; 1990; 42(1-2):43-5. PubMed ID: 2217631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]